News | March 28, 2024
Asahi Songwon Colors acquires remaining 22% stake in Atlas Life Sciences
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
WINREVAIR is a breakthrough biologic for this rare, progressive disease
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
The pilot plant is focused on scaling up beverage production and will support applications
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
To accelerate the development of next-generation radioconjugates to treat cancer
Subscribe To Our Newsletter & Stay Updated
